Company Directory / research

PrivateFor profitresearchMelbourne, Australia
PolyActiva develops products that enable drug release from medical devices.
Size
11-50 people: larger than 33% of companies with a size listed
Age
17 years old.
Reach
No web traffic ranking listed.
BiotechnologyHealth CareMedicalPharmaceutical
Funding, as listed
$26M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about PolyActiva, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
PolyActiva may be growing as it is listed among key companies in the open-angle glaucoma market, which is expected to show positive growth. The company operates in the ocular hypertension market, which is influenced by a growing aging population, indicating a potentially increasing demand for their products. Furthermore, PolyActiva is mentioned in the context of sustained-release drug delivery in glaucoma, suggesting involvement in innovative treatment methods that could contribute to its growth.
Summaries written by the source dataset, not by us, and not checked.
research in Australia.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.